Camptosar and hyponatraemia Patient Reports February 11, 2012

Camptosar Side Effects Report #4843602-0
Camptosar side effect was reported by a Health Professional from UNITED STATES on Nov 15, 2005. Male patient, 73 years of age, weighting 128.1 lb, was diagnosed with rectal cancer and was treated with Camptosar. After drug was administered, patient experienced the following side effects: abdominal pain , asthenia, diarrhoea, gastroenteritis radiation, hypokalaemia, hyponatraemia, malignant neoplasm progression, nausea . Camptosar dosage: 50 MG (50 MG CYCLIC INTERVAL:EVERY WEEK) INTRAVENOUS. During the same period patient was treated with CAPECITABINE, HYDROCODONE BITARTRATE, LOPERAMIDE, HYDROCORTISONE. Patient was hospitalized. Patient died on 11/06/2005.

Camptosar Side Effects Report #4759322-7
Camptosar side effect was reported by a Physician from JAPAN on July 28, 2005. Male patient was diagnosed with ill-defined disorder and was treated with Camptosar. After drug was administered, patient experienced the following side effects: hypochloraemia, hyponatraemia. Camptosar dosage: 80 MG/M2 (1 IN 2 WK), INTRAVENOUS. Patient was hospitalized. Patient recovered.

Camptosar Side Effects Report #4845417-6
Camptosar side effect was reported by a Physician from FRANCE on Nov 14, 2005. Female patient, 76 years of age, was diagnosed with colon cancer and was treated with Camptosar. After drug was administered, patient experienced the following side effects: diabetes mellitus, hyponatraemia, ketonuria, nervous system disorder, pain , septic shock, skin exfoliation, skin lesion, skin toxicity. Camptosar dosage: 250 MG (TOTAL), INTRAVENOUS. During the same period patient was treated with CETUXIMAB. Patient died.

Camptosar Side Effects Report #5826447-4
Camptosar side effect was reported by a Physician from JAPAN on July 17, 2008. Female patient, 74 years of age, was diagnosed with colon cancer and was treated with Camptosar. After drug was administered, patient experienced the following side effects: hyponatraemia. Camptosar dosage: DAILY DOSE:140MG. During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM. Patient died on 07/16/2008.


Camptosar Side Effects Report #6018642-9
Camptosar side effect was reported by a Physician from JAPAN on Dec 10, 2008. Female patient, 74 years of age, weighting 74.96 lb, was diagnosed with colon cancer, nutritional support , pyrexia and was treated with Camptosar. After drug was administered, patient experienced the following side effects: hyponatraemia. Camptosar dosage: 140 MG (120.7 MG), UNK. During the same period patient was treated with FLUOROURACIL, CALCIUM LEVOFOLINATE, DEXAMETHASONE PHOSPHATE, KYTRIL, ENSURE, CRAVIT. Patient died on 07/16/2008.

Camptosar Side Effects Report #5991674-2
Camptosar side effect was reported by a Physician from JAPAN on Nov 25, 2008. Female patient was diagnosed with colon cancer, nutritional support , pyrexia and was treated with Camptosar. After drug was administered, patient experienced the following side effects: hyponatraemia. Camptosar dosage: 140 MG, UNK. During the same period patient was treated with FLUOROURACIL, CALCIUM LEVOFOLINATE, DEXAMETHASONE PHOSPHATE, KYTRIL, ENSURE, CRAVIT. Patient died on 07/16/2008.

Camptosar Side Effects Report #4692208-5
Camptosar side effect was reported by a Physician from on June 01, 2005. Male patient, 63 years of age, was diagnosed with adenocarcinoma and was treated with Camptosar. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood lactate dehydrogenase increased, depressed level of consciousness, diarrhoea, hypocalcaemia, hypoglycaemia, hyponatraemia, hypophosphataemia, nausea . Camptosar dosage: 240 MG (CYCLIC DAY 1) INTRAVENOUS. During the same period patient was treated with XELODA, ERBITUX, GLYBURIDE, BISOPROLOL FUMARATE, MOLSIDOMINE, RAMIPRIL, CLOPIDOGREL HYDROGENOSULPHATE. Patient was hospitalized. Patient recovered.

Camptosar Side Effects Report #4640452-5
Camptosar side effect was reported by a Physician from on Apr 06, 2005. Female patient, 61 years of age, weighting 174.0 lb, was treated with Camptosar. After drug was administered, patient experienced the following side effects: hyponatraemia, iatrogenic injury, malignant neoplasm progression, nausea , non-small cell lung cancer. Camptosar dosage: 45 MG/M2 (CYCLE 3, D1+8, Q21DAYS), INTRAVENOUS. During the same period patient was treated with CISPLATIN, ATENOLOL, DEMECLOCYCLINE, ONDANSETRON, LISINOPRIL, LORAZEPAM, MAGNESIUM OXIDE, POTASSIUM ACETATE. Patient was hospitalized. Patient recovered.

Camptosar Side Effects Report #5600862-6
Camptosar side effect was reported by a Health Professional from UNITED STATES on Jan 22, 2008. Male patient, weighting 196.0 lb, was treated with Camptosar. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, hypokalaemia, hyponatraemia. Camptosar dosage: 297MG EVERY 2 WEEKS IV. Patient was hospitalized. Patient recovered.


Camptosar Side Effects Report #5044384-2
Camptosar side effect was reported by a Physician from JAPAN on June 16, 2006. Male patient was treated with Camptosar. After drug was administered, patient experienced the following side effects: hypochloraemia, hyponatraemia. Camptosar dosage: 80 MG/M2 (1 IN 2 WK) INTRAVENOUS. Patient was hospitalized. Patient recovered.

Camptosar Side Effects Report #5045922-6
Camptosar side effect was reported by a Physician from JAPAN on June 16, 2006. Male patient was treated with Camptosar. After drug was administered, patient experienced the following side effects: hypochloraemia, hyponatraemia. Camptosar dosage: 80 MG/M2 (1 IN 2 WK), INTRAVENOUS. Patient was hospitalized. Patient recovered.